SavedAdd your journal

Journals / Journal of Experimental and Clinical Medicine / 2022 / Cilt: 39 - Sayı: 1

Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10

Fikret ALTINDAĞ
Pages
216–220
Publication Date
2022-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings reveal that SIL may ameliorates the CP-induced nephrotoxicity in rats by inducing downregulation of TNF-α and NF-kB expressions and upregulation of IL-10 expression

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cisplatin (CP) is one of the antineoplastic agents used to treat many types of cancers.
📊
Key Findings & Data:Albino Wistar male rats were randomly divided into four groups (n=7): Control group was administered saline (0.5 ml) for 10 days intraperitoneally (IP), CP group was received CP (a single dose of 8 mg/kg, IP), CP+ SIL group was administered saline (0.5 ml) for 10 days and was received CP (a single dose of 8 mg/kg).
💡
Conclusion & Impact:These findings reveal that SIL may ameliorates the CP-induced nephrotoxicity in rats by inducing downregulation of TNF-α and NF-kB expressions and upregulation of IL-10 expression
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cisplatin · IL-10 · Nephrotoxicity

Abstract

Cisplatin (CP) is one of the antineoplastic agents used to treat many types of cancers. Besides these effects of CP, it causes various side effects such as nephrotoxicity. Inflammation is considered to be one of the main pathogeneses of CP-induced nephrotoxicity. Silymarin (SIL) is a flavonoid with beneficial pharmacological properties such as antioxidant and anti-inflammatory. The current study aimed to investigate the beneficial effects of Silymarin against CP-induced nephrotoxicity. Albino Wistar male rats were randomly divided into four groups (n=7): Control group was administered saline (0.5 ml) for 10 days intraperitoneally (IP), CP group was received CP (a single dose of 8 mg/kg, IP), CP+ SIL group was administered saline (0.5 ml) for 10 days and was received CP (a single dose of 8 mg/kg). To measure the inflammatory response, TNF-α, NF-kB and IL-10 expressions were performed. As a result, TNF-α and NF-kB expressions significantly increased while IL-10 expression decreased in the kidney of the CP group compared to the control group. However, SIL treatment significantly decreased TNF-α and NF-kB expressions and increased IL-10 expression in kidney CP-treated rats. These findings reveal that SIL may ameliorates the CP-induced nephrotoxicity in rats by inducing downregulation of TNF-α and NF-kB expressions and upregulation of IL-10 expression

🔖

Cite This Article

ALTINDAĞ, F. (2022). Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10. Journal of Experimental and Clinical Medicine, Cilt: 39 - Sayı: 1, 216–220. https://ajindex.com/articles/677788

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Abdelmeguid, N. E., Chmaisse, H. N., Abou Zeinab, N. S., 2010a. Protective Effect of Silymarin on Cisplatin-induced Nephrotoxicity in Rats. Pak. J. Nutr. 9(7), 1680–5194.
  2. Abdelmeguid, N. E, Chmaisse, H. N., Abou Zeinab, N. S., 2010b. Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: histopathological and ultrastructural studies. P. J. B. S. 13(10), 463-479.
  3. Bamboat, Z. M., Ocuin, L. M., Balachandran, V. P., Obaid, H., Plitas, G., Dematteo, R. P., 2010. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 120(2), 559–569.
  4. Chen, G. Y., Nunez, G., 2010. Sterile inflammation: sensing and reacting to damage. Nature Reviews Immunology.10, 826–837.
  5. Chen, I. S., Chen, Y. C., Chou, C. H., Chuang, R. F., Sheen, L. Y., Chiu, C. H., 2012. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. J. Sci. Food Agric. 92(7), 1441–1447.
  6. Chen, X., Wei, W., Li, Y., Huang, J., Ci, X., 2019. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chemico-Biological Interactions. 308, 269-278.
  7. Dasari, S., Tchounwou, P. B., 2014. Cisplatin in cancer therapy: molecular mechanisms of action. European Journal of Pharmacology. 740, 364-378.
  8. Gao, L., Liu, M.-M., Zang, H.-M., Ma, Q.-Y., Yang, Q., Jiang, L., Ren, G.-L., Li, H.-D., Wu, W.-F., Wang, J.-N., Wei, B., Liu, X.-Q., Jiang, C., Huang, C., Li, J., Meng, M., 2018.Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death. Laboratory Investigation. 98, 911–923.
  9. Gawad, S. H. A., Mohamed, A. A. K., 2010. Silymarin administration protects against cisplatin-induced nephrotoxicity in adult male albino rats. Egypt. J. Histol. 33(4),683-691. Gómez-Sierra, T., Eugenio-Perez, D., Sanchez-Chinchillas, A., Pedraza-Chaverri, J., 2018. Role of food-derived antioxidants against cisplatin induced-nephrotoxicity. Food and Chemical Toxicology. 120, 230-242.
  10. Güntürk, İ., Yazici, C., Köse, K., Dağli, F., Yücel, B., Yay, A., 2019. The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model. Turk J. Med. Sci. 49, 1789-1799.
  11. Jahan, S., Khan, M., Imran, S., Sair, M., 2015. The hepatoprotective role of Silymarin in isoniazid induced liver damage of rabbits. J. Pak. Med. Assoc. 65(6), 620-2.
  12. Kim, M. G. Yang, H. N.,, Kim, H. W., Jo, S. K., Cho, W. Y., Kim, K. K.,